Stay updated on Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-08T14:20:58.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The EV-302 study record page now renders a 403 Forbidden error, replacing the usual study content with a minimal error screen. The page shows a Home button instead of the detailed study information.
    Difference
    17%
    Check dated 2026-09-24T18:33:46.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.6 to v3.7.0, indicating a minor update to the page metadata.
    Difference
    0.0%
    Check dated 2026-09-17T20:16:33.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    - Tel Litwinsky, Israel, 52621 was added as a study site. - Qiryat Krinitzi, Israel, 52621 was removed from the participating sites.
    Difference
    0.1%
    Check dated 2026-09-10T18:07:52.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The Israeli recruitment site Tel Litwinsky was removed and a new site, Qiryat Krinitzi, was added, updating the list of enrollment locations in Israel.
    Difference
    0.1%
    Check dated 2026-09-03T19:04:06.000Z thumbnail image
  7. Check
    42 days ago
    Change Detected
    Summary
    The page now includes a 2019 U.S. NIH grant/contract acknowledgment and adds a publication citation about the overall survival findings related to EV-302. These additions provide background references and funding context for the study.
    Difference
    0.0%
    Check dated 2026-08-27T17:47:16.000Z thumbnail image

Stay in the know with updates to Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial page.